688366 昊海生科
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入2,074,8114.69%2,654,0392,130,2761,766,9941,332,427
减:营业总成本1,699,5605.15%2,187,7431,864,4201,483,2111,140,866
    其中:营业成本613,7899.24%782,849660,761492,922334,004
               财务费用(34,084)-28.92%(62,217)(74,097)(84,854)(99,123)
               资产减值损失(13,132)170.21%(6,741)(54,239)687(3,970)
公允价值变动收益(345)-116.05%2,296(7,784)24--
投资收益97-91.99%1,1425,80862,17236,845
    其中:对联营企业和合营企业的投资收益81-84.51%4563,5052,193(131)
营业利润387,531-0.28%507,413234,586383,410259,010
利润总额386,440-0.75%508,261235,727382,650257,025
减:所得税费用70,45812.95%95,99145,39535,36630,686
净利润315,983-3.36%412,269190,332347,284226,338
减:非控股权益(24,906)-15,245.51%(3,852)9,862(4,951)(3,732)
股东净利润340,8894.31%416,121180,470352,235230,070

市场价值指针
每股收益 (元) *1.4606.57%2.4401.0402.0001.300
每股派息 (元) *0.400--1.0000.4000.7000.500
每股净资产 (元) *24.124-27.57%32.94931.67032.49630.985
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容